Skip to main content

The Role of Glucocorticoid-Induced Phospholipase Inhibitory Proteins

  • Chapter
Drugs Affecting Leukotrienes and Other Eicosanoid Pathways

Part of the book series: NATO ASI Series ((NSSA,volume 95))

Abstract

Glucocorticoids are powerful anti-inflammatory agents. Although their chief clinical utility in the treatment of acute and chronic inflammatory processes the knowledge of the mode of action of gluco -corticoids is still fragmentary. However at least some anti-inflammatory effects of glucocorticoids depend on their ability to prevent the formation of arachidonic acid oxidation products, i.e. the prostaglandins and leukotrienes which are important mediators of the inflammatory response. Glucocorticoids although do not inhibit cyclo-oxygenase or lipoxygenase are able to prevent phospholipid deacylation from occurring in intact cells by inhibiting phospholipase A2 thereby causing a shortage of precursor arachidonic acid.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. J.D. Baxter and G.M. Tomkins, Specific cytoplasmic glucocorticoid hormone receptors in hepatoma tissue culture cells, Proc. natn. Acad. Sci. USA 68: 932 (1971).

    Article  CAS  Google Scholar 

  2. R.E. Buller and B.W. O’Malley, The biology and mechanism of steroid hormone receptor interaction with the eukaryotic nucleus, Biochem. Pharmac. 25: 1 (1976).

    CAS  Google Scholar 

  3. L. Chan and B.W. O’Malley, Mechanism of action of the sex steroid hormones, New Engl. J. Med. 294: 1372 (1976).

    CAS  Google Scholar 

  4. A. Danon and G. Assouline, Inhibition of prostaglandins by corticosteroids requires RNA and protein synthesis. Nature, Lond. 273: 552 (1978).

    Article  CAS  Google Scholar 

  5. M. Di Rosa and P. Persico, Mechanism of inhibition of prostaglandin biosynthesis by hydrocortisone in rat leucocytes, Br. J. Pharmacol. 66: 161 (1979).

    PubMed  Google Scholar 

  6. R.J. Flower and G.J. Blackwell, Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature Lond. 275: 456 (1979).

    Article  Google Scholar 

  7. R. Carnuccio, M. Di Rosa and P. Persico, Hydrocortisone induced inhibitor of prostaglandin biosynthesis in rat leucocytes. Br. J. Pharmacol. 68: 14 (1980).

    PubMed  CAS  Google Scholar 

  8. G.J. Blackwell, R. Carnuccio, M. Di Rosa, R.J. Flower, L. Parente and P. Persico, Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids, Nature Lond. 287: 147 (1980).

    Article  PubMed  CAS  Google Scholar 

  9. F. Hirata, E. Schiffman, K. Venkatasubramanian, D. Salomon and J.A. Axelrod, Phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids Proc. natn. Acad. Sci. USA 77: 2535 (1980).

    Google Scholar 

  10. J.F. Cloix, 0. Colard, B. Rothhut and F. Russo-Marie,Characterization and partial purification of ‘renocortins’ two polypeptides formed in renal cells causing the antiphospholipase-like action of glucocorticoids, Br. J. Pharmacol. 79: 313 (1983).

    PubMed  CAS  Google Scholar 

  11. G.J. Blackwell, R. Carnuccio, M. Di Rosa, R.J. Flower, C.S.J. Langham, L. Parente, P. Persico, N.C. Russel-Smith and D. Stone, Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat, Br. J. Pharmacol. 76: 185 (1982).

    PubMed  CAS  Google Scholar 

  12. F. Hirata, M. Notsu, M. Iwata, L. Parente, M. Di Rosa and J.R. Flower, Identification of several species of phospholipase inhibitory proteins by radioimmunoassay for lipomodulin, Biochem. biophys. Res. Commun. 109: 223 (1982).

    Google Scholar 

  13. P. Coote, M. Di Rosa, J.R. Flower, L. Parente, M. Merrett and J. Wood, Detection and isolation of a steroid-induced anti-phospholipase protein of high molecular weight, Br. J. Pharmacol. 80: 597 (1983).

    Google Scholar 

  14. B. Rothhut, F. Russo-Marie, J. Wood, M. Di Rosa and R.J. Flower, Further characterization of the glucocorticoidinduced anti-phospholipase protein ‘renocortin’, Biochem. biophys. Res. Commun. 117: 878 (1984).

    Google Scholar 

  15. G.J. Blackwell, Specificity and inhibition of glucocorticoidinduced macrocortin secretion from rat peritoneal macrophage, Br. J. Pharmac., 79: 587 (1983).

    CAS  Google Scholar 

  16. F. Hirata, The regulation of lipomodulin a phospholipase inhibitory protein in rabbit neutrophils by phosphorylation, J. Biol. Chem., 256: 7730 (1981).

    PubMed  CAS  Google Scholar 

  17. L. Parente, M. Di Rosa, J.R. Flower, P. Ghiara, R. Meli, P. Persico, J.A. Salmon and J.N. Wood, Relationship between the anti-phospholipase and anti-inflammatory effect of glucocorticoid-induced proteins, Eur. J. Pharmac., 99: 233 (1984).

    Article  CAS  Google Scholar 

  18. A. Calignano, R. Carnuccio, M. Di Rosa, A. Ialenti and S. oncada, The anti-inflammatory effect of glucocorticoídinduced phospholipase inhibitory proteins, Agents and Actions (in press 1984).

    Google Scholar 

  19. M. Di Rosa and D.A. Willoughby, Screens for anti-inflammatory drugs, J. Pharm. Pharmac., 23: 297 (1971).

    Article  Google Scholar 

  20. T. Hattori, T. Hoffman and F. Hirata, Differentiation of a histiocytic lymphoma cell line by lipomodulin a phospholipase inhibitory protein, Biochem. Biophys. Res.Commun., 111: 551 (1983).

    Article  CAS  Google Scholar 

  21. T. Uede, F. Hirata, M. Hirashima and K. Ishizaka, Modulaton of the biological activities of IgE binding factors I. Identification of glycosilation-inhibiting factor as a fragment of lipomodulin, J. Immunol., 130: 878 (1983).

    PubMed  CAS  Google Scholar 

  22. M. Koltai, I. Lepràn, G.Y. Nemecz and L. Szekeres, The possible mechanism of protection by dexamethasone against sudden death due to coronary ligation in conscious rats, Br. J. Pharmac., 79: 327 (1983).

    CAS  Google Scholar 

  23. F. Hirata, R. Del Carmine, C.A. Nelson, J. Axelrod, E. Schiff-mann, A. Warabi and Others, Presence of autoantibody for phospholipase inhibitory protein lipomodulin in patients with rheumatic diseases, Proc. natn. Acad. Sci. USA, 78: 3190 (1981).

    Article  CAS  Google Scholar 

  24. G. Ciabattoni, P. Patrignani, P. Filabozzi, A. Pierucci, B. Simonetti, G.A. Cinotti, E. Pinca, E. Gotti, G. Remuzzi and C. Patrono, Increased renal thromboxane (TX) production in systemic lupus erythematosus (SLE), Clin. Res., 30: 445A (1982).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Plenum Press, New York

About this chapter

Cite this chapter

Di Rosa, M. (1985). The Role of Glucocorticoid-Induced Phospholipase Inhibitory Proteins. In: Samuelsson, B., Berti, F., Folco, G.C., Velo, G.P. (eds) Drugs Affecting Leukotrienes and Other Eicosanoid Pathways. NATO ASI Series, vol 95. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7841-9_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-7841-9_25

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-7843-3

  • Online ISBN: 978-1-4684-7841-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics